CSIMarket
 


Stryker Corp  (SYK)
Other Ticker:  
 
 

SYK's Revenue Growth by Quarter and Year

Stryker's Revenue results by quarter and year




SYK Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 5,202.00 4,701.00 4,262.00
III Quarter September - 4,479.00 4,160.00 3,737.00
II Quarter June 4,996.00 4,493.00 4,294.00 2,764.00
I Quarter March 4,778.00 4,275.00 3,953.00 3,588.00
FY   9,774.00 18,449.00 17,108.00 14,351.00



SYK Revenue second quarter 2023 Y/Y Growth Comment
Stryker Corp achieved in the second quarter 2023, above Company average Revenue increase of 11.2% year on year, to $ 4,996.00 millions.

Looking into second quarter 2023 results within Medical Equipment & Supplies industry 60 other companies have achieved higher Revenue growth. While Stryker Corp' s Revenue growth of 11.2% ranks overall at the positon no. 928 in the second quarter 2023.




SYK Revenue ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - 10.66 % 10.3 % 3.17 %
III Quarter September - 7.67 % 11.32 % 4.18 %
II Quarter June 11.2 % 4.63 % 55.35 % -24.27 %
I Quarter March 11.77 % 8.15 % 10.17 % 2.05 %
FY   - 7.84 % 19.21 % -3.58 %

Financial Statements
Stryker's second quarter 2023 Revenue $ 4,996.00 millions SYK's Income Statement
Stryker's second quarter 2022 Revenue $ 4,493.00 millions Quarterly SYK's Income Statement
New: More SYK's historic Revenue Growth >>


SYK Revenue (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - 16.14 % 13 % 14.05 %
III Quarter September - -0.31 % -3.12 % 35.2 %
II Quarter June 4.56 % 5.1 % 8.63 % -22.97 %
I Quarter March -8.15 % -9.06 % -7.25 % -13.14 %
FY (Year on Year)   - 7.84 % 19.21 % -3.58 %




Revenue second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #61
Healthcare Sector #211
Overall #928

Revenue Y/Y Growth Statistics
High Average Low
55.35 % 8.95 % -24.27 %
(Jun 30 2021)   (Jun 30 2020)
Revenue second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #61
Healthcare Sector #211
Overall #928
Revenue Y/Y Growth Statistics
High Average Low
55.35 % 8.95 % -24.27 %
(Jun 30 2021)   (Jun 30 2020)

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Stryker's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
35.2 % 2.47 % -22.97 %
(Sep 30 2020)  


SYK's II. Quarter Q/Q Revenue Comment
Stryker Corp achieved in the II. Quarter 2023 above company average sequential Revenue growth of 4.56%, to $ 4,996.00 millions, from $4,778.00 millions in the first quarter.

Within Medical Equipment & Supplies industry 39 other companies have achieved higher Revenue quarter on quarter growth. While Stryker's Revenue growth quarter on quarter, overall rank is 665.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #40
Healthcare Sector #113
Overall #665
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #40
Healthcare Sector #113
Overall #665
Revenue Q/Q Growth Statistics
High Average Low
35.2 % 2.47 % -22.97 %
(Sep 30 2020)  


SYK's II. Quarter Q/Q Revenue Comment
Stryker Corp achieved in the II. Quarter 2023 above company average sequential Revenue growth of 4.56%, to $ 4,996.00 millions, from $4,778.00 millions in the first quarter.

Within Medical Equipment & Supplies industry 39 other companies have achieved higher Revenue quarter on quarter growth. While Stryker's Revenue growth quarter on quarter, overall rank is 665.


Stryker's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
Cumulative Revenue 12 Months Ending $ 19,455.00 $ 18,952.00 $ 18,449.00 $ 17,948.00 $ 17,629.00
Y / Y Revenue Growth (TTM) 10.36 % 8.73 % 7.84 % 7.67 % 8.51 %
Year on Year Revenue Growth Overall Ranking # 771 # 153 # 782 # 1765 # 413
Seqeuential Revenue Change (TTM) 2.65 % 2.73 % 2.79 % 1.81 % 1.14 %
Seq. Revenue Growth (TTM) Overall Ranking # 1151 # 2063 # 1704 # 1777 # 2529




Cumulative Revenue growth Comment
Stryker saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 10.36% year on year, to $ 19,455 millions if the fiscal year would have ended in Jun 30 2023.
Stryker's trailing twelve months Revenue growth was higher than company's average 8.58% and higher than 8.73% growth in Mar 31 2023.
But from the previous reporting period rise was less at 2.65 % from $18952 millions reported in twelve months ending a quarter before.
We witness slowdown happening, more evident observing the usual sequential Revenue increase what is stronger at8.58%.
The growth was much stronger sequentially showed at 2.65 % rise from $18952 millions in the period from Mar 31 2023 to Jun 30 2022.

In the Healthcare sector 91 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 153 to 771.

Revenue TTM Q/Q Growth Statistics
High Average Low
19.21 %
8.58 %
-4.34 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 42
Healthcare Sector # 92
Overall # 771

Revenue TTM Y/Y Growth Statistics
High Average Low
19.21 %
8.58 %
-4.34 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 42
Sector # 121
S&P 500 # 1151
Cumulative Revenue growth Comment
Stryker saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 10.36% year on year, to $ 19,455 millions if the fiscal year would have ended in Jun 30 2023.
Stryker's trailing twelve months Revenue growth was higher than company's average 8.58% and higher than 8.73% growth in Mar 31 2023.
But from the previous reporting period growth rate was beneth at 2.65 % from $18952 millions reported in twelve months ending a quarter Mar 31 2023 Jasper  Surname continued.
It appears to be drop-off in progress, more obvious observing the usual Q/Q TTM historic increase which is better at8.58% Jasper  Surname noted.
The growth is even higher from the previous reporting period exhibited at 2.65 % jump from $18952 millions in twelve months ending a quarter Mar 31 2023.

In the Healthcare sector 91 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 153 to 771.

Revenue TTM Q/Q Growth Statistics
High Average Low
19.21 %
8.58 %
-4.34 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 42
Healthcare Sector # 92
Overall # 771

Revenue TTM Y/Y Growth Statistics
High Average Low
19.21 %
8.58 %
-4.34 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 42
Sector # 121
S&P 500 # 1151




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
SYK's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for SYK's Competitors
Revenue Growth for Stryker's Suppliers
Revenue Growth for SYK's Customers

You may also want to know
SYK's Annual Growth Rates SYK's Profitability Ratios SYK's Asset Turnover Ratio SYK's Dividend Growth
SYK's Roe SYK's Valuation Ratios SYK's Financial Strength Ratios SYK's Dividend Payout Ratio
SYK's Roa SYK's Inventory Turnover Ratio SYK's Growth Rates SYK's Dividend Comparisons



Companies with similar Revenue growth for the quarter ending Jun 30 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2023
Talkspace Inc 19.44%$ 19.438 millions
Atricure Inc 19.39%$ 19.389 millions
Dariohealth Corp 19.36%$ 19.355 millions
Lemaitre Vascular Inc 18.95%$ 18.947 millions
Zomedica Corp 18.89%$ 18.888 millions
Amphastar Pharmaceuticals Inc 18.02%$ 18.017 millions
Deciphera Pharmaceuticals Inc 17.88%$ 17.880 millions
Infusystem Holdings Inc17.35%$ 17.354 millions
Alimera Sciences Inc 17.18%$ 17.180 millions
Establishment Labs Holdings Inc 17.17%$ 17.167 millions
Immunitybio inc 17.14%$ 17.143 millions
Amicus Therapeutics inc 16.92%$ 16.918 millions
Stereotaxis Inc 16.82%$ 16.824 millions
Assertio Holdings inc 16.68%$ 16.680 millions
Intercept Pharmaceuticals inc 16.67%$ 16.669 millions
Lifemd Inc 16.22%$ 16.219 millions
Interpace Biosciences Inc 15.87%$ 15.870 millions
Bruker Corporation15.82%$ 15.823 millions
Livanova Plc15.63%$ 15.633 millions
Biolase Inc 15.39%$ 15.390 millions
Qhslab Inc 15.38%$ 15.379 millions
Intuitive Surgical Inc 15.36%$ 15.360 millions
Heron Therapeutics Inc 14.95%$ 14.955 millions
Conmed Corporation14.60%$ 14.597 millions
Docgo Inc 14.58%$ 14.580 millions
Tactile Systems Technology Inc 14.51%$ 14.509 millions
Clearpoint Neuro Inc 14.42%$ 14.423 millions
Elite Pharmaceuticals Inc 14.04%$ 14.045 millions
Radnet Inc 13.92%$ 13.923 millions
Corcept Therapeutics Inc13.86%$ 13.860 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com